↓ Skip to main content

Cochrane Database of Systematic Reviews

Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis

Overview of attention for article published in Cochrane database of systematic reviews, July 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
4 tweeters

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
83 Mendeley
Title
Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis
Published in
Cochrane database of systematic reviews, July 2012
DOI 10.1002/14651858.cd002767.pub2
Pubmed ID
Authors

Lil Breen, Nivedita Aswani

Abstract

Pseudomonas aeruginosa is the commonest micro-organism associated with respiratory infections in cystic fibrosis. Retrospective studies have suggested that using an aggressive policy of intravenous anti-pseudomonal antibiotics at regular intervals, irrespective of symptoms, increases survival.

Twitter Demographics

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 83 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
India 1 1%
Unknown 81 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 14%
Researcher 8 10%
Student > Doctoral Student 7 8%
Other 6 7%
Student > Postgraduate 6 7%
Other 23 28%
Unknown 21 25%
Readers by discipline Count As %
Medicine and Dentistry 29 35%
Agricultural and Biological Sciences 5 6%
Nursing and Health Professions 4 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Immunology and Microbiology 3 4%
Other 11 13%
Unknown 27 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 November 2014.
All research outputs
#12,664,757
of 22,671,366 outputs
Outputs from Cochrane database of systematic reviews
#9,719
of 12,296 outputs
Outputs of similar age
#87,007
of 164,330 outputs
Outputs of similar age from Cochrane database of systematic reviews
#125
of 171 outputs
Altmetric has tracked 22,671,366 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,296 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 164,330 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 171 others from the same source and published within six weeks on either side of this one. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.